Rhythm Pharmaceuticals, Inc. (BMV:RYTM)

Mexico · Delayed Price · Currency is MXN

1,866.76

-158.24 (-7.81%)

At close: Nov 18, 2025

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Product Revenue, Net	179.35M	130.13M	77.43M
Product Revenue, Net Growth	37.83%	68.06%	358.59%
Revenue (Other)	-5.01M	-	-
Revenue (Total)	174.33M	130.13M	77.43M
Revenue (Total) Growth	33.97%	68.06%	227.56%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States Revenue	126.29M	96.11M	62.43M
United States Revenue Growth	31.41%	53.96%	196.16%
International Revenue	53.06M	34.02M	15.00M
International Revenue Growth	55.97%	126.74%	486.06%
Revenue (Other)	-5.01M	-	-
Revenue (Total)	174.33M	130.13M	77.43M
Revenue (Total) Growth	33.97%	68.06%	227.56%

Updated Sep 30, 2025. Data Source: Fiscal.ai.